Sympathetic activity, blood pressure variability and end organ damage in hypertension

Journal of Human Hypertension

Volumn 11, Issue SUPPL. 1, 1997, Pages

  Mancia, G ^a,c   Di Rienzo, M ^b   Parati, G ^c   Grassi, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Antihypertensive treatment; Blood pressure variability; End organ damage; Essential hypertension; Obesity; Sympathetic nervous system

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GANGLION BLOCKING AGENT; INSULIN; NORADRENALIN;

ANTIHYPERTENSIVE ACTIVITY; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR RISK; DISEASE SEVERITY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; NORADRENALIN BLOOD LEVEL; OBESITY; PATHOPHYSIOLOGY; PRESSORECEPTOR REFLEX; REVIEW; SMOKING; SYMPATHETIC NERVE; SYMPATHETIC TONE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HEART; HUMANS; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; SYMPATHETIC NERVOUS SYSTEM;

EID: 0030865966     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Mancia G. Neural factors in hypertension. In: Chazov E, Smirnov V (eds). Cardiology: an international perspective. Plenum Press: New York, 1984, pp 309-318.
2. Goldstein DS. Plasma norepinephrine in essential hypertension. A study of the studies. Hypertension 1981; 3: 48-52.
3. Esler M, Lambert GW, Jennings G. Regional norepinephrine turnover in human hypertension. Clin Exper Hypertens 1989; 11 (Suppl 1): 75-89.
4. Yamada Y et al. Impaired baroreflex changes in muscle sympathetic nerve activity in adolescents who have a family history of essential hypertension. J Hypertens 1988; 6 (Suppl 4): 525S-528S.
5. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Hypertension 1989; 14: 177-183.
6. Grassi G et al. Baroreceptor control of heart rate and sympathetic nerve traffic in mild and severe essential hypertension. J Hypertens 1994; 112 (Suppl 3): S8 (abstract).
7. Grassi G et al. Sympathetic nerve traffic and baroreflex control of circulation in secondary hypertension. J Hypertens 1996; 14 (Suppl 1): S114 (abstract).
8. Grassi G et al. Sympathetic activation in obese normotensive subjects. Hypertension 1995; 25: 560-563.
9. Grassi G et al. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma norepinephrine in man. Clin Sci 1997; 92: 285-289.
10. Grassi G et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994; 90: 248-253.
11. Winniford MD et al. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone. Circulation 1986; 73: 662-667.
12. Trap-Jensen J. Effects of smoking on the heart and peripheral circulation. Am Heart J 1988; 115: 263-267.
13. Giannattasio C et al. Acute effects of smoking on radial artery compliance in humans. J Hypertens 1994; 12: 691-696.
14. Groppelli A et al. Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992; 10: 495-499.
15. Mann SJ, James GD, Wang RS, Pickering TG. Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study. JAMA 1991; 265: 2226-2228.
16. Ferranini E et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357.
17. Mancia G, Saino A, Grassi G. Interactions between the sympathetic nervous system and the renin angiotensin system. In: Laragh J, Brenner B (eds). Hypertension: Pathophysiology, Diagnosis and Management. Raven Press: New York, 1995, pp 399-407.
18. Simpson P, McGrath A, Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 1982; 51: 787-801.
19. Blaes N, Boissel JP. Growth-stimulating effect of catecholamines on rat aortic smooth muscle cells in culture. J Cell Physiol 1983; 116: 167-172.
20. Sen S, Tarazi RC, Khairallah PA, Bumpus FM. Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res 1974; 35: 775-781.
21. Grassi G et al. Sympathetic modulation of radial artery compliance in congestive heart failure. Hypertension 1995; 26: 348-354.
22. Boutouyrie P et al. Sympathetic activation decreases medium-size arterial compliance in humans. Am J Physiol 1994; 267: H1368-H1376.
23. Mangoni AA et al. Heart rate-dependance of arterial distensibility in vivo. J Hypertens 1996; 14: 897-901.
24. Mancia G, Parati G, Di Rienzo M, Zanchetti A. Blood pressure variability. In: Zanchetti A, Mancia G (eds). Handbook of Hypertension, vol 17 Pathophysiology of Hypertension. Elsevier Science: Amsterdam, 1997, pp 117-169.
25. Mancia G et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983; 53: 96-104.
26. Parati G et al. Relationship of 24-hour blood pressure mean and variability to severity of target organ damage in hypertension. J Hypertens 1987; 5: 93-98.
27. Palatini P et al. Clinical relevance of night-time blood pressure and of day-time blood pressure variability. Arch Int Med 1992; 152: 1855-1860.
28. Frattola A et al. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993; 11: 1133-1137.
29. Parati G et al. Effects of aging on 24 hour dynamic baroreceptor control of heart rate in ambulant subjects. Am J Physiol 1995; 268: H1606-H1612.
30. Falkner B, Onesti G, Hamstra B. Stress response characteristics of adolescents with high genetic risk of essential hypertension: a five-year follow-up. Clin Exper Hypertens 1981; 3: 583-591.
31. Timio M et al. Age and blood pressure changes: a 20 year follow-up study of nuns in a secluded order. Hypertension 1988; 12: 457-461.
32. Schnall PL et al. The relationship between 'job strain', work place, diastolic blood pressure and left ventricular mass index. JAMA 1990; 263: 1929-1935.
33. Parati G et al. Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans. Hypertension 1988; 12: 214-222.
34. Perondi R et al. ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease. Circulation 1992; 85: 2004-2013.
35. Saino A et al. Intracoronary angiotensin II potentiates coronary sympathetic vasoconstriction in man. Circulation 1997; (in press).
36. Grassi G et al. Effects of body weight reduction on sympathetic nerve traffic and baroreflex control of circulation in obese normotensive subjects. Proc VII Eur Meet on Hypertens, Milan 1995; (Suppl 3): 73 (abstract).
37. Grassi G et al. Baroreflex impairment by low sodium diet in mild or moderate essential hypertension. Hypertension 1997; 29: 802-807.